3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Squamous Cell Carcinoma of Head and Neck
4
Nasopharyngeal Carcinoma
3
Melanoma
3
Esophageal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Vascular Complications
1
Stomach Neoplasms
1
Spinocerebellar Degenerations
1
Solid Tumor
1
Recurrence
1
Rectal Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Complete Response
1
Oropharyngeal Neoplasms
1
Oligoprogressive
1
Neoplasms
1
Neoplasm Metastasis
1
NSCLC
1
Mouth Neoplasms
1
Meningeal Carcinomatosis
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Locally Advanced Rectal Cancer
1
Immune-Related Adverse Events
1
Glioma
1
Esophageal Squamous Cell Carcinoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Cancer Metastatic
1
Interventions
Specimen Handling
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Biopsy
2
dehydroftorafur
1
X-Rays
1
Watchful Waiting
1
Taxes
1
Sigmoidoscopy
1
Radiotherapy, Intensity-Modulated
1
Proctoscopy
1
Phantoms, Imaging
1
Paclitaxel
1
Observation
1
Mitozytrex
1
Mitomycin
1
Ipilimumab
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Colonoscopy
1
Carboplatin
1
Capecitabine
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anal Canal Carcinoma
×
Immune Checkpoint Inhibitors
×
90 days
×
Clear all
No trials found.